Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2000 | 09-1999 | 09-1998 | 09-1993 | 09-1992 | |
| Sales | 25 | 30 | 60 | 47 | 25 |
| Cost of Goods | 2 | 3 | 30 | 23 | 9 |
| Gross Profit | 23 | 30 | 20 | 24 | 27 |
| Operating Expenses | 134 | 93 | 90 | 785 | 603 |
| Operating Income | -109 | -63 | -30 | -739 | -579 |
| Interest Expense | 122 | 100 | 40 | 14 | 6 |
| Other Income | 94 | -197 | 20 | 3 | -157 |
| Pre-tax Income | -138 | -360 | -50 | -750 | -742 |
| Net Income Continuous | -138 | -360 | -50 | -750 | -742 |
| Net Income Discontinuous | N/A | 960 | 0 | 0 | 0 |
| Net Income | $-138 | $590 | $-50 | $-750 | $-742 |
| EPS Basic Total Ops | -19.48 | 1.59 | -11.13 | -468.59 | -824.33 |
| EPS Basic Continuous Ops | -17.79 | -0.97 | -11.13 | -258.55 | -824.33 |
| EPS Basic Discontinuous Ops | N/A | 2.59 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -19.48 | N/A | N/A | -258.55 | -824.33 |
| EPS Diluted Continuous Ops | -17.79 | N/A | N/A | -258.55 | -824.33 |
| EBITDA(a) | $-102 | $-55 | $-20 | $-546 | $-488 |